Clover Health Investments (CLOV) Stock Price, News & Analysis

Company Overview

Clover Health Investments is a technology-driven healthcare company specializing in Medicare Advantage plans for senior populations. The company combines insurance coverage with a proprietary software platform to improve care coordination, outcomes tracking and cost management. By leveraging data analytics, Clover Health aims to deliver personalized care pathways and preventive interventions for its members.

At the core of Clover’s offering is its Clover Assistant platform, which aggregates clinical and claims data from multiple sources to create real-time insights for physicians and care teams. This platform flags gaps in care, offers evidence-based treatment suggestions and facilitates member outreach to ensure adherence to preventive screenings and chronic condition management. Clover’s insurance products cover hospitalization, outpatient care, prescription drug benefits and various supplemental services, including telehealth and transportation assistance.

Founded in 2014 by Vivek Garipalli and Kris Gale and headquartered in Jersey City, New Jersey, Clover Health has expanded its Medicare Advantage footprint across several U.S. states. The company serves beneficiaries in urban and rural markets, with operations spanning regions such as the Northeast, Southeast and Midwest. Under the leadership of its co-founders, Clover continues to invest in data science, artificial intelligence and member engagement tools to drive clinical quality improvements and cost efficiencies throughout its network.

Key Stats

• Today's Range: $2.55 to $2.64
• 50-Day Range: $2.18 to $3.25
• 52-Week Range: $2.12 to $4.87
• Volume: 1.62 million shs
• Average Volume: 7.29 million shs
• Market Capitalization: $1.35 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.37
• Consensus Rating: Hold

Clover Health Investments Stock Analysis - MarketRank™

Clover Health Investments scored higher than 43% of companies evaluated by MarketBeat, and ranked 614th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Hold

Consensus Rating

Clover Health Investments has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 2 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Clover Health Investments has a consensus price target of $4.37, representing about 68.6% upside from its current price of $2.59.

Amount of Analyst Coverage

Clover Health Investments has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Clover Health Investments are expected to grow in the coming year, from ($0.12) to ($0.07) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Clover Health Investments is -32.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Clover Health Investments is -32.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Clover Health Investments has a P/B Ratio of 3.81. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.62% of the outstanding shares of Clover Health Investments have been sold short.

Short Interest Ratio / Days to Cover

Clover Health Investments has a short interest ratio ("days to cover") of 5.6.

Change versus previous month

Short interest in Clover Health Investments has recently increased by 1.97%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Clover Health Investments does not currently pay a dividend.

Dividend Growth

Clover Health Investments does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

9.62% of the outstanding shares of Clover Health Investments have been sold short.

Short Interest Ratio / Days to Cover

Clover Health Investments has a short interest ratio ("days to cover") of 5.6.

Change versus previous month

Short interest in Clover Health Investments has recently increased by 1.97%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Clover Health Investments this week, compared to 5 articles on an average week.

Search Interest

Only 22 people have searched for CLOV on MarketBeat in the last 30 days. This is a decrease of -8% compared to the previous 30 days.

MarketBeat Follows

5 people have added Clover Health Investments to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Clover Health Investments insiders have sold 909.64% more of their company's stock than they have bought. Specifically, they have bought $68,635.00 in company stock and sold $692,968.00 in company stock.

Percentage Held by Insiders

24.07% of the stock of Clover Health Investments is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 19.77% of the stock of Clover Health Investments is held by institutions.

CLOV Stock Analysis - Frequently Asked Questions

How have CLOV shares performed this year?

Clover Health Investments' stock was trading at $3.15 at the start of the year. Since then, CLOV stock has decreased by 17.8% and is now trading at $2.59.

How were Clover Health Investments' earnings last quarter?

Clover Health Investments, Corp. (NASDAQ:CLOV) posted its quarterly earnings data on Tuesday, May, 6th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.12. The firm had revenue of $462.33 million for the quarter, compared to analyst estimates of $466.93 million. Clover Health Investments had a negative trailing twelve-month return on equity of 12.20% and a negative net margin of 2.68%.
Read the conference call transcript.

How do I buy shares of Clover Health Investments?

Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Clover Health Investments own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Clover Health Investments investors own include Zomedica (ZOM), AMC Entertainment (AMC), SoFi Technologies (SOFI), Jumia Technologies (JMIA), NIO (NIO), Meta Platforms (META) and NVIDIA (NVDA).

Company Calendar

• Last Earnings: 5/06/2025
• Today: 10/06/2025
• Next Earnings (Estimated): 11/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Insurance
• Current Symbol: NASDAQ:CLOV
• CIK: 1801170
• Web: www.cloverhealth.com
• Phone: 201-432-2133
• Fax: N/A
• Employees: 680
• Year Founded: 2014

Price Target and Rating

• Average Price Target for Clover Health Investments: $4.37
• High Price Target: $6.00
• Low Price Target: $3.00
• Potential Upside/Downside: +68.6%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.08)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$43.01 million
• Net Margins: -2.68%
• Pretax Margin: -2.62%
• Return on Equity: -12.20%
• Return on Assets: -6.95%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.80
• Quick Ratio: 1.80

Sales & Book Value

• Annual Sales: $1.37 billion
• Price / Sales: 0.97
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.68 per share
• Price / Book: 3.81

Miscellaneous

• Outstanding Shares: 512,510,000
• Free Float: 389,151,000
• Market Cap: $1.33 billion
• Optionable: Optionable
• Beta: 2.10